PharmApprove, a member of the NDA Group

PharmApprove is the leading strategic, regulatory and scientific communications consultancy to the pharmaceutical and biotech industries in the US, Canada and Europe. We equip life sciences innovators with the right message, as well as the skills to deliver it, helping them prepare to win by making complex scientific arguments comprehensible and compelling.We offer both strategic and tactical support to companies facing high-profile, high-stakes events and engagements anywhere along the road to approval and commercialization. We help them win health authority approvals, deliver compelling regulatory communications, and make persuasive pharmacoeconomic arguments to payers and HTAs.Over the past 19 years, PharmApprove’s pioneering approach to strategic, regulatory and scientific communications has produced a winning record for our clients: We’ve helped more than 150 sponsor teams and over 1,500 presenters make and defend their best case for product approvals. And we have an 85% success rate at crucial FDA Advisory Committee meetings; successfully steering companies through those challenging public hearings is our longstanding specialty.PharmApprove is the trusted advisor that helps pharmaceutical and device teams prepare to win — in the US, Canada and Europe.